Literature DB >> 1449140

Gastric acid secretion in HIV-1 infection.

R T Shaffer1, L J LaHatte, J W Kelly, S Kadakia, J G Carrougher, R F Keate, E C Starnes.   

Abstract

It has been suggested that AIDS patients may have reduced gastric acid output. This is of concern because gastric acid may be required for absorption of oral antifungal agents that are important in AIDS management. The cause as well as the progression of reduced gastric acid output in AIDS patients is unclear. This study investigated gastric acid output in relation to the stage of non-AIDS HIV-1-infected patients. No statistical difference was found between nine control and 26 male HIV-infected subjects in basal acid output, maximal acid output, peak acid output, or fasting serum gastrin, regardless of stage. Likewise, no relationship between stage of HIV infection and gastric acid output was determined. We conclude that there is no impairment in basal and maximally stimulated gastric acid secretion in non-AIDS HIV-1-infected males. In addition, the clinical stage of non-AIDS HIV-1 infection has no effect on gastric acid secretion.

Entities:  

Mesh:

Year:  1992        PMID: 1449140

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV-1 infected patients.

Authors:  C M Wilcox; K B Waites; P D Smith
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 2.  Helicobacter pylori infection and drugs malabsorption.

Authors:  Edith Lahner; Camilla Virili; Maria Giulia Santaguida; Bruno Annibale; Marco Centanni
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study.

Authors:  S Mouly; G Aymard; J P Tillement; C Caulin; J F Bergmann; S Urien
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

4.  Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.

Authors:  G D Morse; M A Fischl; M J Shelton; S R Cox; M Driver; M DeRemer; W W Freimuth
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Changes in parietal cell structure and function in HIV disease.

Authors:  G Lake-Bakaar; M Elsakr; N Hagag; S Lyubsky; J Ahuja; B Craddock; R T Steigbigel
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

6.  Low prevalence of H. pylori infection in HIV-positive patients in the northeast of Brazil.

Authors:  Andréa B C Fialho; Manuel B Braga-Neto; Eder J C Guerra; André M N Fialho; Karine C Fernandes; Juliana L M Sun; Christianne F V Takeda; Cícero I S Silva; Dulciene M M Queiroz; Lucia L B C Braga
Journal:  BMC Gastroenterol       Date:  2011-02-19       Impact factor: 3.067

7.  Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population.

Authors:  Joe Geraghty; Alexander Thumbs; Anstead Kankwatira; Tim Andrews; Andrew Moore; Rose Malamba; Neema Mtunthama; Kai Hellberg; Lughano Kalongolera; Paul O'Toole; Andrea Varro; D Mark Pritchard; Melita Gordon
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

8.  High prevalence of gastric intestinal metaplasia detected by confocal laser endomicroscopy in Zambian adults.

Authors:  Violet Kayamba; Aaron Shibemba; Kanekwa Zyambo; Douglas C Heimburger; Douglas R Morgan; Paul Kelly
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.